These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18519727)

  • 1. Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
    Lemaire S; Olivier A; Van Bambeke F; Tulkens PM; Appelbaum PC; Glupczynski Y
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2797-805. PubMed ID: 18519727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of acidic pH in the susceptibility of intraphagocytic methicillin-resistant Staphylococcus aureus strains to meropenem and cloxacillin.
    Lemaire S; Van Bambeke F; Mingeot-Leclercq MP; Glupczynski Y; Tulkens PM
    Antimicrob Agents Chemother; 2007 May; 51(5):1627-32. PubMed ID: 17307986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Lemaire S; Glupczynski Y; Duval V; Joris B; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2289-97. PubMed ID: 19289525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular forms of menadione-dependent small-colony variants of methicillin-resistant Staphylococcus aureus are hypersusceptible to β-lactams in a THP-1 cell model due to cooperation between vacuolar acidic pH and oxidant species.
    Garcia LG; Lemaire S; Kahl BC; Becker K; Proctor RA; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2012 Dec; 67(12):2873-81. PubMed ID: 23002174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
    Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y
    J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levonadifloxacin (WCK 771) exerts potent intracellular activity against
    Dubois J; Dubois M
    J Med Microbiol; 2019 Dec; 68(12):1716-1722. PubMed ID: 31689174
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenotypic and genotypic characterization of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible Staphylococcus aureus (MSSA) from different sources in China.
    Chao G; Zhang X; Zhang X; Huang Y; Xu L; Zhou L; Yang W; Jiang Y; Xue F; Wu Y
    Foodborne Pathog Dis; 2013 Mar; 10(3):214-21. PubMed ID: 23405883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis.
    Castañeda X; García-De-la-Mària C; Gasch O; Pericàs JM; Soy D; Cañas-Pacheco MA; Falces C; García-González J; Hernández-Meneses M; Vidal B; Almela M; Quintana E; Tolosana JM; Fuster D; Llopis J; Dahl A; Moreno A; Marco F; Miró JM;
    J Antimicrob Chemother; 2021 May; 76(6):1539-1546. PubMed ID: 33837406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Sodium Bicarbonate on Wall Teichoic Acid Synthesis and β-Lactam Sensitization in NaHCO
    Ersoy SC; Gonçalves B; Cavaco G; Manna AC; Sobral RG; Nast CC; Proctor RA; Chambers HF; Cheung A; Bayer AS
    Microbiol Spectr; 2022 Dec; 10(6):e0342222. PubMed ID: 36377886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the NaHCO
    Fan SH; Proctor RA; Ersoy SC; Manna AC; Cheung AL; Götz F; Chambers HF; Bayer AS
    Microbiol Spectr; 2023 Jun; 11(3):e0014123. PubMed ID: 37102972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro synergistic activity between meropenem and other beta-lactams against methicillin-resistant Staphylococcus aureus.
    Sumita Y; Mitsuhashi S
    Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):77-84. PubMed ID: 1864279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin.
    Mélard A; Garcia LG; Das D; Rozenberg R; Tulkens PM; Van Bambeke F; Lemaire S
    J Antimicrob Chemother; 2013 Mar; 68(3):648-58. PubMed ID: 23188792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Lozniewski A; Lion C; Mory F; Weber M
    J Antimicrob Chemother; 2001 Jan; 47(1):83-6. PubMed ID: 11152435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Nomura S; Hanaki H; Unemi N
    Chemotherapy; 1996; 42(4):253-8. PubMed ID: 8804792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinations of cefoxitin plus other β-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureus.
    Banerjee R; Fernandez MG; Enthaler N; Graml C; Greenwood-Quaintance KE; Patel R
    Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):827-33. PubMed ID: 23340864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.
    Mehta S; Singh C; Plata KB; Chanda PK; Paul A; Riosa S; Rosato RR; Rosato AE
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6192-200. PubMed ID: 22985884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus.
    Sharma AD; Gutheil WG
    Microbiol Spectr; 2023 Feb; 11(1):e0372622. PubMed ID: 36519895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.